Form 4 for RNTX Rein Therapeutics, Inc.
Accepted 2026-05-13 08:47:13 ET · period of report 2026-04-30 · accession 0001193125-26-220718 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-13 08:47 | 2026-04-30 | RNTX | WINDSOR JAMES BRIAN | See Remarks, Dir | P - Purchase | $1.00 | +25.0K | 27.0K | +1,222% | +$25.0K |
| D | 2026-05-13 08:47 | 2026-05-08 | RNTX | WINDSOR JAMES BRIAN | See Remarks, Dir | A - Grant | $0.00 | -150.0K | 150.0K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock , $0.001 par value | 2026-04-30 | P | A | 25,000 | $1.00 | 27,046 | D | — | — | (F1) Shares purchased in Issuer's April 30, 2026 follow-on public offering. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-08 | A | D | 150,000 | $0.00 | 150,000 | D | $1.17 · — to 2036-05-08 | 150,000 Common Stock | (F2) This option was granted on May 8, 2026. The 25% of the shares underlying the option are scheduled to vest on May 8, 2027 and thereafter in equal monthly installments through May 8, 2031. |